Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1995 Oct;102(1):65–70. doi: 10.1111/j.1365-2249.1995.tb06637.x

Antifungal mechanisms of activated murine bronchoalveolar or peritoneal macrophages for Histoplasma capsulatum.

E Brummer 1, D A Stevens 1
PMCID: PMC1553340  PMID: 7554402

Abstract

The first line of defence against natural infection by Histoplasma capsulatum (Hc) consists of bronchoalveolar macrophages (BAM) and an early inflammatory response in the lungs. Little is known about the interaction of BAM and Hc, consequently we studied murine BAM in vitro to assess their role in the pulmonary defence in histoplasmosis. A short-term 3-h assay was used to measure fungicidal activity of control BAM and interferon-gamma (IFN-gamma) plus lipopolysaccharide (LPS)-activated BAM. Fungistatic activity of BAM was determined with a 24-h assay. A method devised for measuring colony-forming units (CFU) of non-ingested non-adherent and adherent ingested yeast cells of Hc in BAM cocultures was used. Activated BAM killed Hc (reduced inoculum CFU by 25 +/- 12%; n = 4). The fungicidal activity of BAM was abrogated by 0.2 mM NG-monomethyl-L-arginine (NMMA) or catalase but not by superoxide dismutase. In fungistatic assays activated BAM inhibited multiplication of Hc by 61 +/- 4% (n = 3) compared with cocultures with control BAM. However, Hc multiplied 100% more in control BAM cocultures than in medium alone. Data indicated that this was due to advantages that Hc has in the intracellular environment. Only NMMA inhibited fungistatic activity of activated BAM. In experiments with peritoneal macrophages (PM), results similar to those with BAM were obtained. In conclusion, activated BAM and PM kill yeast cells of Hc by a mechanism dependent on hydrogen peroxide and products of the nitric oxide synthase (NOS) pathway, whereas fungistasis depends only on products of the NOS pathway.

Full text

PDF
69

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brummer E., Kurita N., Yoshida S., Nishimura K., Miyaji M. Killing of Histoplasma capsulatum by gamma-interferon-activated human monocyte-derived macrophages: evidence for a superoxide anion-dependent mechanism. J Med Microbiol. 1991 Jul;35(1):29–34. doi: 10.1099/00222615-35-1-29. [DOI] [PubMed] [Google Scholar]
  2. Brummer E., Kurita N., Yosihida S., Nishimura K., Miyaji M. Fungistatic activity of human neutrophils against Histoplasma capsulatum: correlation with phagocytosis. J Infect Dis. 1991 Jul;164(1):158–162. doi: 10.1093/infdis/164.1.158. [DOI] [PubMed] [Google Scholar]
  3. Brummer E., Morrison C. J., Stevens D. A. Recombinant and natural gamma-interferon activation of macrophages in vitro: different dose requirements for induction of killing activity against phagocytizable and nonphagocytizable fungi. Infect Immun. 1985 Sep;49(3):724–730. doi: 10.1128/iai.49.3.724-730.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brummer E., Stevens D. A. Activation of pulmonary macrophages for fungicidal activity by gamma-interferon or lymphokines. Clin Exp Immunol. 1987 Dec;70(3):520–528. [PMC free article] [PubMed] [Google Scholar]
  5. Brummer E., Stevens D. A. Candidacidal mechanisms of peritoneal macrophages activated with lymphokines or gamma-interferon. J Med Microbiol. 1989 Mar;28(3):173–181. doi: 10.1099/00222615-28-3-173. [DOI] [PubMed] [Google Scholar]
  6. Brummer E., Stevens D. A. Effect of macrophage colony-stimulating factor (M-CSF) on macrophage morphology, phagocytosis, and intracellular multiplication of Histoplasma capsulatum. Int J Immunopharmacol. 1994 Feb;16(2):171–176. doi: 10.1016/0192-0561(94)90073-6. [DOI] [PubMed] [Google Scholar]
  7. Calich V. L., Purchio A., Paula C. R. A new fluorescent viability test for fungi cells. Mycopathologia. 1979 Feb 28;66(3):175–177. doi: 10.1007/BF00683967. [DOI] [PubMed] [Google Scholar]
  8. Cano L. E., Gomez B., Brummer E., Restrepo A., Stevens D. A. Inhibitory effect of deferoxamine or macrophage activation on transformation of Paracoccidioides brasiliensis conidia ingested by macrophages: reversal by holotransferrin. Infect Immun. 1994 Apr;62(4):1494–1496. doi: 10.1128/iai.62.4.1494-1496.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Granger D. L., Hibbs J. B., Jr, Perfect J. R., Durack D. T. Specific amino acid (L-arginine) requirement for the microbiostatic activity of murine macrophages. J Clin Invest. 1988 Apr;81(4):1129–1136. doi: 10.1172/JCI113427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Graybill J. R. Histoplasmosis and AIDS. J Infect Dis. 1988 Sep;158(3):623–626. doi: 10.1093/infdis/158.3.623. [DOI] [PubMed] [Google Scholar]
  11. Green S. J., Nacy C. A., Meltzer M. S. Cytokine-induced synthesis of nitrogen oxides in macrophages: a protective host response to Leishmania and other intracellular pathogens. J Leukoc Biol. 1991 Jul;50(1):93–103. doi: 10.1002/jlb.50.1.93. [DOI] [PubMed] [Google Scholar]
  12. HOWARD D. H. INTRACELLULAR GROWTH OF HISTOPLASMA CAPSULATUM. J Bacteriol. 1965 Feb;89:518–523. doi: 10.1128/jb.89.2.518-523.1965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hamilton T. A., Gray P. W., Adams D. O. Expression of the transferrin receptor on murine peritoneal macrophages is modulated by in vitro treatment with interferon gamma. Cell Immunol. 1984 Dec;89(2):478–488. doi: 10.1016/0008-8749(84)90348-4. [DOI] [PubMed] [Google Scholar]
  14. Kimberlin C. L., Hariri A. R., Hempel H. O., Goodman N. L. Interactions between Histoplasma capsulatum and macrophages from normal and treated mice: comparison of the mycelial and yeast phases in alveolar and peritoneal macrophages. Infect Immun. 1981 Oct;34(1):6–10. doi: 10.1128/iai.34.1.6-10.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kurita N., Brummer E., Yoshida S., Nishimura K., Miyaji M. Antifungal activity of murine polymorphonuclear neutrophils against Histoplasma capsulatum. J Med Vet Mycol. 1991;29(3):133–143. [PubMed] [Google Scholar]
  16. Kwon-Chung K. J., Tewari R. P. Determination of viability of Histoplasma capsulatum yeast cells grown in vitro: comparison between dye and colony count methods. J Med Vet Mycol. 1987 Apr;25(2):107–114. [PubMed] [Google Scholar]
  17. Lane T. E., Wu-Hsieh B. A., Howard D. H. Iron limitation and the gamma interferon-mediated antihistoplasma state of murine macrophages. Infect Immun. 1991 Jul;59(7):2274–2278. doi: 10.1128/iai.59.7.2274-2278.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Nakamura L. T., Wu-Hsieh B. A., Howard D. H. Recombinant murine gamma interferon stimulates macrophages of the RAW cell line to inhibit intracellular growth of Histoplasma capsulatum. Infect Immun. 1994 Feb;62(2):680–684. doi: 10.1128/iai.62.2.680-684.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Newman S. L., Gootee L., Gabay J. E. Human neutrophil-mediated fungistasis against Histoplasma capsulatum. Localization of fungistatic activity to the azurophil granules. J Clin Invest. 1993 Aug;92(2):624–631. doi: 10.1172/JCI116630. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. PROCKNOW J. J., PAGE M. I., LOOSLI C. G. Early pathogenesis of experimental histoplasmosis. Arch Pathol. 1960 Apr;69:413–426. [PubMed] [Google Scholar]
  21. SCHWARZ J. The pathogenesis of histoplasmosis. Trans N Y Acad Sci. 1958 Apr;20(6):541–548. doi: 10.1111/j.2164-0947.1958.tb00618.x. [DOI] [PubMed] [Google Scholar]
  22. Salzman S. H., Smith R. L., Aranda C. P. Histoplasmosis in patients at risk for the acquired immunodeficiency syndrome in a nonendemic setting. Chest. 1988 May;93(5):916–921. doi: 10.1378/chest.93.5.916. [DOI] [PubMed] [Google Scholar]
  23. Sugar A. M., Brummer E., Stevens D. A. Murine pulmonary macrophages: evaluation of lung lavage fluids, miniaturized monolayers, and candidacidal activity. Am Rev Respir Dis. 1983 Jan;127(1):110–112. doi: 10.1164/arrd.1983.127.1.110. [DOI] [PubMed] [Google Scholar]
  24. Vodovotz Y., Kwon N. S., Pospischil M., Manning J., Paik J., Nathan C. Inactivation of nitric oxide synthase after prolonged incubation of mouse macrophages with IFN-gamma and bacterial lipopolysaccharide. J Immunol. 1994 Apr 15;152(8):4110–4118. [PubMed] [Google Scholar]
  25. Wolf J. E., Kerchberger V., Kobayashi G. S., Little J. R. Modulation of the macrophage oxidative burst by Histoplasma capsulatum. J Immunol. 1987 Jan 15;138(2):582–586. [PubMed] [Google Scholar]
  26. Wu-Hsieh B. A., Howard D. H. Inhibition of the intracellular growth of Histoplasma capsulatum by recombinant murine gamma interferon. Infect Immun. 1987 Apr;55(4):1014–1016. doi: 10.1128/iai.55.4.1014-1016.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES